Facet Biotech

Type: Company
Name: Facet Biotech
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

Who's going places?

Oxford BioTherapeutics, a company developing antibody-drug conjugates (ADCs) for cancer, has appointed Keith Wilson as Chief Scientific Officer (CSO). He joins the company from AbbVie, where he was Global Leader for Antibody Drug Conjugates.Wilson has ... [Published In-Pharmatechnologist - Jul 01 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer

– Portfolio company Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, announced today the appointment of Dr Keith E Wilson as Chief Scientific ... [Published Catapult - Jun 26 2014]

More Content

All (2) | News (2) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Who's going places? [Published In-Pharmatechnologist - Jul 01 2014]
Oxford BioTherapeutics Appoints Dr Keith E Wils... [Published Catapult - Jun 26 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.